NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

ADVERTISMENT

ADVERTISMENT

Irish Pharmacist November 2024

By Irish Pharmacist - 07th Nov 2024

Welcome to the November 2024 issue of Irish Pharmacist, where we bring you in-depth insights, the latest industry updates, and essential clinical content for Ireland’s pharmacy community.

In this issue, we celebrate excellence within our field in “Credit Where It’s Due,” with a spotlight on the finalists for this year’s Irish Pharmacy Excellence Awards. Join us as we honour the individuals and teams leading innovation and exemplary service in Irish pharmacy.

In “Fatal Attraction,” Dr. Des Corrigan examines a concerning trend: nine out of 10 overdose fatalities now involve prescribed or over-the-counter (OTC) medicines, raising critical questions about prescribing practices and patient safety.

Our Clinical Content section, tailored “by pharmacists, for pharmacists,” covers pivotal areas such as Women’s Health, Colds and Flu, and Digestive Health, with expert perspectives to support your practice.

And finally, in “All About Windsor,” the Chief Executive of the Irish Medicines Verification Organisation (IMVO) breaks down the Windsor Framework’s implications for Irish pharmacists, offering insights on the adjustments you’ll need to make in light of these new guidelines.

We hope this issue informs, supports, and inspires your work in Irish pharmacy.

ADVERTISMENT

Latest News

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist December 2024

Irish Pharmacist December 2024

Read

OTC Autumn 2024

In this issue of OTC Update we focus on hydration, hair care, sports injuries, fatigue, and menopause…

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT